Atrial Fibrillation

  • Vincent E. Friedewald


Calculate CHA2DS2-VASc SCORE for thromboembolic risk [26]


International Normalize Ratio FABRY Disease Atrial Flutter Antithrombotic Therapy Direct Thrombin Inhibitor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities Google Scholar
  2. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation Google Scholar
  3. Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines Google Scholar
  4. 2012 HRS/EHRA/ECAS Expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design Google Scholar
  5. The Indian consensus guidance on stroke prevention in atrial fibrillation: an emphasis on practical use of nonvitamin K oral anticoagulants Google Scholar

Professional Information

Review: Acute Management

Review: Anticoagulation

Review: Cardiac Fibrosis

Review: Effects Beyond Atrium

Review: Atrial Fibrillation/Heart Failure

Review: Aniarrhythmic Drug Therapy

  1. Circ Arrhythmia Electrophysiol. 2016;9:e002479. doi: 10.1161/CIRCEP.115.002479.

Review: LAA Occlusion

Review: LAA Occlusion

Review: Pathophysiology

Review: Progression from Paroxysmal to Persistent AF

Review: Stroke Prevention

Review: Stroke Prevention

Ablation: Antiarrhythmic Drugs Following

Ablation: Effect on GI Motility

  1. Circulation: Arrhythmia and Electrophysiology. 2015;8:531–6.

Ablation: Gastroparesis as Complication

Ablation: Response/Genetic Variants

  1. Circulation: Arrhythmia and Electrophysiology. 2015;8:296–302.

ACEIS/ARBS for Prevention

Acute Myocardial Infarction/Death

  1. Circulation. 2011;123:2094–100.

Acute Pericarditis

Acute Pulmonary Embolism

  1. J Am Heart Assoc. 2014;3:e000483.

Acute Pulmonary Embolism Risk: CHA2DS2-VASC Score

AF/HF: Quality of Life/Functional Capacity

AF-Related Embolism: Epidemiology

Aerobic Training: Prevention

African Americans: European Ancestry

Air Pollution

Alcohol Consumption: Risk Factor

Alcohol Consumption: Meta-analysis

Alcohol Consumption: Prognosis

Alcohol Consumption: Women



Anemia/Decreased Renal Function


Aortic Stenosis

Aortic Stenosis


Atrial Fibrillation Risk

Atrial Fibrosis

Atrial Fibrosis

Atrial Fibrosis

Atrial Septal Defect


  1. N Engl J Med. 2011;365:981–92.

Atrial Fibrilation/Atrial Flutter

Atrial Fibrillation/Atrial Flutter: ECG Misdiagnosis

Atrial Remodeling

Atrial Remodeling

  1. Circ Arrhythm Electrophysiol. 2008;1:62–73.

Autonomic Ganglia In AF

Bile Acid Composition Effects



Botulinum Toxin Injection for Recurrence Prevention



Cardiac Surgery

Cardiorespiratory Fitness

Cardioversion: Hemodynamic/Exercise Changes

Cardioversion: Post-procedure Thromboembolism

Cognitive Impairment in PTS with HF

Coronary Artery Calcium

  1. Am J Cardiol. 2014;114:1707–12.

Catheter Ablation

Catheter Ablation

Catheter Ablation: Persistent AF

  1. N Engl J Med. 2015;372:1812–22.

Catheter Ablation: Post-procedure Cognitive Dysfunction

Catheter Ablation Versus Drug Therapy

Cholinergic Atrial Fibrillation

CNS Protection (Editorial)

Coffee Consumption

  1. Eur J Prev Cardiol. 2015. pii: 2047487315624524.

Cognitive Impairment

Cognitive Impairment

CRT: Review of 20 Year Experience


  1. N Engl J Med. 2013;369:1206–14.


Dengue Fever

  1. Braz J Infect Dis. 2003;7:418–22.

Diabetes Mellitus: Stroke Risk

Diabetes Mellitus: Subclinical AF/CNS Effects


Digoxin: Risk of Death/Hospitalization

  1. Circulation: Arrhythmia and Electrophysiology. 2015;8:49–58.



  1. N Engl J Med. 2011;365:2268–76.

Dronedarone: Safety

Early Onset Atrial Fibrillation: KCNA5 Variants

Epicardial Adipose Tissue


Ethnicity/Stroke Risk

Familial Atrial Fibrillation

Fish Oil

Galactin-3 Level: Persistent a FIB


  1. Circulation Research. 2014;114:1469–82.

Genetics: SCN10A

  1. Circulation: Cardiovascular Genetics. 2015;8:64–73.

Head Trauma

  1. Emerg Med J. 2003;20:106–8.

Heart Failure

Heart Failure: Catheter Ablation

  1. N Engl J Med. 2004;351:2373–83.

Heart Failure: AF (New Onset) as Predictor of Progression

Heart Failure/Stroke: Symptoms/LV Dysfunction

Heart Transplant

  1. J Cardiovasc Electrophysiol. 2006;17:827–31.


Hypertension: Risk Model for AF



Hypertrophic Cardiomyopathy


  1. Ann Emerg Med. 1990;19:565–7.


Hypothermia: Post-cardiopulmonary Bypass

  1. Crit Care Med. 2000;28:309–11.

Imaging (Noninvasive)

Incidence/Risk Factor for AF in Older Adults (CV Health Study)

Inflammation: Risk Factor

LAA Occlusion: DECR P Wave Dispersion

  1. J Am Heart Assoc. 2015;4:e001581.

LAA Occlusion: Metaanalysis

LAA Occlusion: Prevail Trial (Watchman)

LAA Occlusion: Percutaneous – Lariat

LAA Occlusion

LAA Occlusion

Left Atrial Stiffness

  1. Circ Arrhythmia Electrophysiol. 2016;9:e003163. doi: 10.1161/CIRCEP.115.003163

Left Atrial Structure/Function

Lone Atrial Fibrillation: Histology

Lung Function Reduction: Increased Risk of AF


Mass Screening

Metabolic Syndrome

Mitral Annulus Calcification

  1. Europace. 2014. (Epub ahead of print).

Mitral Annulus Calcification

  1. Atherosclerosis. 2004;173:291–4.

Mitral Regurgitation

Mitral Stenosis/La Thrombus

  1. Am J Cardiol. 2000;86:529–34.

Molecular Pathophysiology

  1. J Clin Invest. 2011;121:2955–68.

Mortality Risk

Muscular Dystrophy




Obesity: Risk for Atrial Fibrillation

Obstructive Sleep Apnea

Obstructive Sleep Apnea/Stroke

Obstructive Sleep Apnea Treatment: AF Recurrence

Oral Antithrombotics (AHA Science Advisory)

Outcomes: Long-Term (Framingham)

P Wave Duration: Risk

Pathophysiology/Prognosis: Imaging

  1. Circulation: Cardiovascular Imaging. 2015;8:e003020.

Pericarditis: Acute

Pericarditis: Constrictive

  1. Ann Noninvasive Electrocardiol. 2009;14:258–61.

Perioperative Atrial Fibrillation

Peripheral Artery Disease

  1. J Am Heart Assoc. 2014;3:e001270.


  1. Rev Port Cardiol. 2014;33:245.e1–4.


  1. Clin Infect Dis. 2007;45:158–65.

Predisposing Factors

Preexcitation Syndromes


QTC Duration/AF Risk

Rate Control

  1. N Engl J Med. 2010;362:1363–73.

Rate/Rhythm Control: Review

  1. Ann Intern Med. 2014;160:760–73.

Renal Dysfunction: Anticoagulants

Rhythm Control: La Dysfunction

Risk Factors: Framingham Heart Study

Risk: Long-Term

Risk: Resting HR/Physical Activity

Risk for Stroke/Bleeding Associated with Antithrombotic Therapy


  1. N Engl J Med. 2011;365:883–91.

Second Hand Smoke Exposure

Sick Sinus Syndrome

Silent Cerebral Ischemia

Silent Stroke

  1. Ann Intern Med. 2014;161:650–8.

Spinal Cord Injury

Statins: Post-OP AF Prevention

  1. J Thorac Cardiovasc Surg. 2010;139:803–4.


  1. N Engl J Med. 2014;370:2467–77.

Stroke: Prevention in Patients with CKD

  1. Circulation. 2016; 133:1512–15.

Stroke: Subclinical AF

Systemic Arterial Hypertension

  1. Am J Cardiol. 2003;91:9G–14G.

Systemic Emboli

Thoracic Surgery

Thromboembolism Risk: CHA2DS2-VASc Score

Vigorous Exercise

Copyright information

© Springer-Verlag London 2016

Authors and Affiliations

  • Vincent E. Friedewald
    • 1
  1. 1.Division of CardiologyUT Health Science Center at Houston Division of CardiologyHoustonUSA

Personalised recommendations